| Literature DB >> 16009909 |
Kala M Mehta1, Maggie Yin, Cynthia Resendez, Kristine Yaffe.
Abstract
Acetylcholinesterase inhibitors (AChIs) have been demonstrated to improve Alzheimer disease symptoms. Whether the use of AChIs varies by ethnicity is unknown. More than 2500 ethnically diverse patients (6% African American, 14% Latino, and 7% Asian patients) from the Alzheimer's Disease Research Centers in California were studied. Compared with white patients with AD, minority patients had 40% lower odds of AChI use (odds ratio 0.6, 95% confidence interval: 0.5 to 0.7).Entities:
Mesh:
Substances:
Year: 2005 PMID: 16009909 PMCID: PMC2830864 DOI: 10.1212/01.wnl.0000167545.38161.48
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910